C07F 9/3205
The acid moiety containing a substituent or a structure which is considered
Official title: {the acid moiety containing a substituent or a structure which is considered as characteristic}
C07F9/3205 (The acid moiety containing a substituent or a structure which is considered) appears on 317 US grants and 157 published applications in this corpus.
Search patents in C07F- Granted patents
- 317
- Published applications
- 157
- Assignees
- 133
- Inventors
- 592
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 6 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 8 | 0 |
| 1982 | 3 | 0 |
| 1983 | 8 | 0 |
| 1984 | 11 | 0 |
| 1985 | 12 | 0 |
| 1986 | 8 | 0 |
| 1987 | 11 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 11 | 0 |
| 1992 | 12 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 10 | 0 |
| 1997 | 13 | 0 |
| 1998 | 8 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 0 |
| 2002 | 4 | 2 |
| 2003 | 5 | 6 |
| 2004 | 2 | 7 |
| 2005 | 2 | 6 |
| 2006 | 5 | 2 |
| 2007 | 0 | 7 |
| 2008 | 1 | 2 |
| 2009 | 5 | 7 |
| 2010 | 5 | 2 |
| 2011 | 4 | 22 |
| 2012 | 3 | 7 |
| 2013 | 6 | 9 |
| 2014 | 12 | 7 |
| 2015 | 11 | 8 |
| 2016 | 5 | 4 |
| 2017 | 7 | 8 |
| 2018 | 6 | 9 |
| 2019 | 10 | 10 |
| 2020 | 9 | 6 |
| 2021 | 7 | 5 |
| 2022 | 6 | 7 |
| 2023 | 1 | 1 |
| 2024 | 1 | 8 |
| 2025 | 5 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07F 9/3211Esters of acyclic saturated acids which can have further substituents on alkyl183
- C07F 9/3241Esters of arylalkanephosphinic acids57
- C07F 9/3229Esters of aromatic acids52
- C07F 9/3217Esters of acyclic unsaturated acids27
- C07F 9/3247Esters of acids containing the structure -c-p or nc-p27
- C07F 9/3223Esters of cycloaliphatic acids12
- C07F 9/3235Esters of polyphosphinic acids12
Recent patents
- Phosphorus-containing compound, manufacturing method thereof, resin composition, and article made therefrom31 Mar 2026US 12,590,109 B2Elite Electronic Material (Kunshan) Co., Ltd.
- Method of producing L-glufosinate27 Jan 2026US 12,534,482 B2Cj Cheiljedang Corporation
- Reagents and their use for modular enantiodivergent synthesis of C—P bonds9 Dec 2025US 12,492,217 B2Bristol-Myers Squibb Company
- Heterocyclic compound and organic light-emitting device comprising same16 Sep 2025US 12,415,823 B2Lt Materials Co., Ltd.
- Acylphosphineoxide initiators10 Jun 2025US 12,325,723 B2Agfa NV
- Reagents and their use for modular enantiodivergent synthesis of c-p bonds21 May 2026US 2026/0138999 A1Bristol-Myers Squibb Company
- Process for the preparation l-glufosinate or salts thereof26 Feb 2026US 2026/0055123 A1
- Brush polymer terminated with phosphonate for dsa17 Jul 2025US 2025/0230265 A1Merck Patent GmbH
- Herbicidal activity of alkyl phosphinates13 Feb 2025US 2025/0049037 A1BASF SE
- L-glufosinate derivative, composition comprising same, preparation method therefor and use thereof13 Feb 2025US 2025/0051374 A1
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Modified PSMA ligands and uses related thereto119US 6,875,886 B2Beth Israel Deaconess Medical Center, Inc. · 2005
- Acylphosphine oxide compounds their preparation and use115US 4,298,738 ABASF SE · 1981
- Acylphosphine oxide compounds113US 4,324,744 ABASF SE · 1982
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994